Skip to main content
Skip to main content
CHE logo

Chemed Corporation (CHE)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Chemed Corporation (CHE) trades at $371.95 with AI Score 46/100 (Weak). Chemed Corporation operates in the healthcare and home services sectors, providing hospice care through VITAS Healthcare and plumbing services through Roto-Rooter. Market cap: 6B, Sector: Healthcare.

Last analyzed: Feb 3, 2026
Chemed Corporation operates in the healthcare and home services sectors, providing hospice care through VITAS Healthcare and plumbing services through Roto-Rooter. With a diversified business model, Chemed addresses essential needs in both healthcare and home maintenance.
46/100 AI Score Target $475.00 (+27.7%) MCap 6B Vol 262K

Chemed Corporation (CHE) Healthcare & Pipeline Overview

CEOKevin J. McNamara
Employees15695
HeadquartersCincinnati, OH, US
IPO Year1973

Chemed Corporation, a leader in hospice care and plumbing services, offers a unique blend of healthcare stability and essential home services, driving consistent revenue and profitability with a diversified business model and a strong market presence in the United States.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 3, 2026

Investment Thesis

Chemed Corporation presents a notable research candidate due to its diversified business model and strong market positions in both hospice care and plumbing services. The VITAS Healthcare segment benefits from the growing demand for hospice care driven by an aging population, while Roto-Rooter provides stable revenue through essential home services. With a P/E ratio of 22.69 and a profit margin of 11.0%, Chemed demonstrates financial stability and profitability. The company's dividend yield of 0.51% offers a modest income stream. Upcoming expansion of VITAS into underserved markets and ongoing operational efficiencies in Roto-Rooter are expected to drive future growth. Investors may want to evaluate Chemed for its diversified revenue streams, stable financial performance, and growth potential in expanding markets.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $6.34B reflects Chemed's significant presence in the healthcare and home services sectors.
  • P/E ratio of 22.69 indicates investor confidence in Chemed's earnings potential.
  • Profit Margin of 11.0% demonstrates effective cost management and profitability.
  • Gross Margin of 32.2% highlights the company's ability to generate revenue after accounting for the cost of goods sold.
  • Beta of 0.46 suggests lower volatility compared to the overall market, making it a relatively stable investment.

Competitors & Peers

Strengths

  • Diversified revenue streams from hospice care and plumbing services.
  • Strong brand recognition and market presence in both segments.
  • Established network of company-owned branches and franchisees.
  • Stable demand for essential services in healthcare and home maintenance.

Weaknesses

  • Exposure to regulatory changes in the healthcare industry.
  • Dependence on referrals for hospice care patients.
  • Potential for increased competition in both segments.
  • Labor-intensive business model with high employee turnover.

Catalysts

  • Aging population driving increased demand for hospice care services.
  • Expansion of VITAS Healthcare into new geographic markets.
  • Implementation of operational efficiencies in Roto-Rooter.
  • Potential acquisitions of smaller hospice providers and plumbing companies.

Risks

  • Changes in government regulations affecting hospice care reimbursement.
  • Economic downturn impacting demand for plumbing services.
  • Increased competition in both the hospice care and plumbing sectors.
  • Rising labor costs and regulatory compliance expenses.
  • Negative publicity or litigation related to service quality or patient care.

Growth Opportunities

  • Expansion of VITAS Healthcare Services: VITAS has the opportunity to expand its hospice care services into underserved geographic areas, particularly in rural communities and regions with limited access to specialized end-of-life care. The market for hospice care is projected to reach $40 billion by 2028, driven by the aging population and increasing awareness of the benefits of hospice. This expansion can be achieved through strategic acquisitions, partnerships with local healthcare providers, and the establishment of new VITAS facilities, enhancing market share and revenue growth.
  • Technological Innovation in Roto-Rooter: Roto-Rooter can leverage technological advancements to improve service delivery and customer experience. Implementing smart plumbing solutions, such as leak detection systems and remote monitoring, can provide added value to customers and differentiate Roto-Rooter from competitors. The market for smart plumbing is expected to grow to $10 billion by 2027, driven by increasing demand for water conservation and efficient home management. Investing in these technologies can attract new customers and enhance customer retention.
  • Strategic Acquisitions: Chemed can pursue strategic acquisitions in both the hospice care and plumbing services sectors to expand its market presence and service offerings. Acquiring smaller hospice providers can provide access to new geographic markets and patient populations. Similarly, acquiring regional plumbing companies can strengthen Roto-Rooter's market share and expand its service capabilities. These acquisitions can be funded through a combination of cash and debt, enhancing Chemed's long-term growth prospects.
  • Enhanced Customer Service and Loyalty Programs: Implementing enhanced customer service initiatives and loyalty programs can improve customer satisfaction and retention in both VITAS and Roto-Rooter. For VITAS, this includes providing additional support services to families and caregivers, such as grief counseling and respite care. For Roto-Rooter, this includes offering discounts and priority service to repeat customers. These initiatives can increase customer loyalty and drive repeat business, contributing to revenue growth and profitability.
  • Partnerships with Healthcare Providers: VITAS can form strategic partnerships with hospitals, nursing homes, and other healthcare providers to increase referrals and expand its reach. These partnerships can involve co-location of VITAS services within healthcare facilities, joint marketing initiatives, and shared electronic health records. By collaborating with other healthcare providers, VITAS can improve access to hospice care for patients and enhance its reputation as a leading provider of end-of-life care.

Opportunities

  • Expansion into underserved geographic markets.
  • Strategic acquisitions to increase market share.
  • Technological innovation to improve service delivery.
  • Partnerships with healthcare providers to increase referrals.

Threats

  • Changes in government reimbursement policies for hospice care.
  • Economic downturn affecting demand for plumbing services.
  • Increased competition from national and regional players.
  • Rising labor costs and regulatory compliance expenses.

Competitive Advantages

  • Established brand reputation in both hospice care (VITAS) and plumbing services (Roto-Rooter).
  • Extensive network of company-owned branches, contractors, and franchisees.
  • Diversified revenue streams from healthcare and home services.
  • Specialized expertise and training in both hospice care and plumbing services.

About CHE

Chemed Corporation, established in 1970 and headquartered in Cincinnati, Ohio, has evolved into a diversified company operating primarily in two distinct segments: VITAS Healthcare and Roto-Rooter. VITAS Healthcare, a significant contributor to Chemed's revenue, provides hospice and palliative care services to patients facing life-limiting illnesses. These services are delivered through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers, ensuring comprehensive care and support for patients and their families. Roto-Rooter, the other key segment, offers plumbing, drain cleaning, excavation, water restoration, and other related services to both residential and commercial customers. This segment operates through a combination of company-owned branches, independent contractors, and franchisees, extending its reach across a wide geographic area. Chemed's strategic diversification allows it to tap into stable demand in both the healthcare and home services sectors, providing a resilient business model. The company's commitment to quality care and reliable service has solidified its position in the market, driving consistent financial performance.

What They Do

  • Provides hospice and palliative care services through VITAS Healthcare.
  • Offers plumbing, drain cleaning, and excavation services through Roto-Rooter.
  • Delivers end-of-life care to patients with life-limiting illnesses.
  • Provides residential and commercial plumbing solutions.
  • Operates through a network of physicians, nurses, and home health aides.
  • Utilizes company-owned branches, contractors, and franchisees for service delivery.
  • Offers water restoration services.

Business Model

  • Generates revenue through hospice care services provided by VITAS Healthcare.
  • Earns revenue from plumbing and drain cleaning services offered by Roto-Rooter.
  • Utilizes a combination of company-owned operations and franchise agreements.
  • Focuses on providing essential services with recurring revenue streams.

Industry Context

Chemed Corporation operates within the healthcare and home services industries, both experiencing steady growth. The hospice care market is expanding due to the aging population and increasing awareness of end-of-life care options. The plumbing services market benefits from ongoing demand for maintenance and repair services in residential and commercial properties. Chemed's competitors include companies like DaVita (DVA) in healthcare and others like Broadridge Financial Solutions (BRKR) in business services, though Roto-Rooter's market is more fragmented. The company's diversified approach allows it to capitalize on the strengths of both industries, mitigating risks associated with relying on a single market.

Key Customers

  • Patients with life-limiting illnesses and their families (VITAS).
  • Residential homeowners requiring plumbing services (Roto-Rooter).
  • Commercial businesses needing plumbing and drain cleaning (Roto-Rooter).
  • Healthcare facilities seeking hospice care partners (VITAS).
AI Confidence: 72% Updated: Feb 3, 2026

Financials

Chart & Info

Chemed Corporation (CHE) stock price: $371.95 (-2.07, -0.55%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CHE.

Price Targets

Consensus target: $475.00

MoonshotScore

46/100

What does this score mean?

The MoonshotScore rates CHE's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Common Questions About CHE (Healthcare)

What does Chemed Corporation do?

Chemed Corporation operates primarily through two segments: VITAS Healthcare and Roto-Rooter. VITAS Healthcare provides hospice and palliative care services to patients facing life-limiting illnesses, offering a network of physicians, nurses, and other healthcare professionals. Roto-Rooter offers plumbing, drain cleaning, excavation, and water restoration services to residential and commercial customers. The company's diversified business model allows it to tap into stable demand in both the healthcare and home services sectors, providing a resilient business model and consistent financial performance.

Is CHE stock worth researching?

Chemed Corporation's stock presents a mixed outlook. The company's diversified business model provides stability, with VITAS Healthcare benefiting from the aging population and Roto-Rooter offering essential home services. However, potential regulatory changes in healthcare and economic fluctuations could impact performance. With a P/E ratio of 22.69 and a profit margin of 11.0%, Chemed demonstrates financial stability. Investors may want to evaluate the company's growth opportunities, such as expanding VITAS into underserved markets, against potential risks before making an investment decision. A balanced approach is recommended.

What are the main risks for CHE?

Chemed Corporation faces several key risks. Changes in government regulations and reimbursement policies for hospice care could significantly impact VITAS Healthcare's revenue. Economic downturns could reduce demand for Roto-Rooter's plumbing services. Increased competition in both the hospice care and plumbing sectors could erode market share. Rising labor costs and regulatory compliance expenses could squeeze profit margins. Negative publicity or litigation related to service quality or patient care could damage the company's reputation and financial performance. These risks require careful monitoring and mitigation strategies.

What are the key factors to evaluate for CHE?

Chemed Corporation (CHE) currently holds an AI score of 46/100, indicating low score. The stock trades at a P/E of 20.3x, near the S&P 500 average (~20-25x). Analysts target $475.00 (+28% from $371.95). Key strength: Diversified revenue streams from hospice care and plumbing services. Primary risk to monitor: Changes in government regulations affecting hospice care reimbursement. This is not financial advice.

How frequently does CHE data refresh on this page?

CHE prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CHE's recent stock price performance?

Recent price movement in Chemed Corporation (CHE) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $475.00 implies 28% upside from here. Notable catalyst: Diversified revenue streams from hospice care and plumbing services. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CHE overvalued or undervalued right now?

Determining whether Chemed Corporation (CHE) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 20.3. Analysts target $475.00 (+28% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CHE?

Before investing in Chemed Corporation (CHE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2026-02-03.
  • Future performance is subject to market conditions and company-specific factors.
Data Sources

Popular Stocks